Rigel Pharmaceuticals (RIGL) EPS (Diluted) Growth (5y) (2015 - 2026)
Rigel Pharmaceuticals (RIGL) EPS (Diluted) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.82% |
| Dec 31, 2025 | 70.67% |
| Sep 30, 2025 | 30.16% |
| Jun 30, 2025 | 38.78% |
| Mar 31, 2025 | -12.95% |
| Dec 31, 2024 | 22.77% |
| Sep 30, 2024 | 24.79% |
| Jun 30, 2024 | 45.60% |
| Mar 31, 2024 | 14.87% |
| Dec 31, 2023 | -68.14% |
| Sep 30, 2023 | 25.56% |
| Jun 30, 2023 | 24.82% |
| Mar 31, 2023 | 14.00% |
| Dec 31, 2022 | 15.39% |
| Sep 30, 2022 | 4.91% |
| Jun 30, 2022 | 12.90% |
| Mar 31, 2022 | -3.46% |
| Dec 31, 2021 | 5.70% |
| Sep 30, 2021 | 13.83% |
| Jun 30, 2021 | 12.06% |